Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high- risk Stage II and III colon cancers? Three years' follow- up results of the PRODIGE 22 phase II randomized multicentre trial
https://t.co/hFQrFVDjS1
#colorectalsurgery
During the Education Core Subject Update at #ESCP2022 on 21 September, Gaetano Luglio will be presenting on anal fissure - make sure to register to not miss out!
https://t.co/H5mOWHv8nV
#ESCP#Coloproctology
Join @bjsinghmd at #ESCP2022 for his talk on acute diverticulitis during the Education Core Subject Update on 21 September - a session not to be missed!
Register your place: https://t.co/ZFgmo2SKcO
#ESCP#Coloproctology
Registration is now open and this time we are face-to face & online! Hosted at the magnificent Glaziers Hall, London, join us for the 20th @StMarksHospital Annual International Congress, Frontiers in Colorectal & Intestinal Disease! @DrAilsaHart https://t.co/EzWcsoOXXh
A new video has been uploaded to the BJS YouTube channel: ‘Cambridge twist’: overlooked detail when teaching continuous sutures https://t.co/T40hFl2gMK
🧵regarding Allis forceps:
What they're used for, some of the history, including why their design was probably a misunderstanding, and why they're not even like other Allis forceps, much less like Babcock forceps, which are something else entirely.
Last 48 hrs Ive been hearing all the reasons why universal health care in other countries sucks: high taxes, wait times, lower pay. All due respect to these problems, but we have system designed to make a handful of corporations immense profit by denying medical care to everybody
Congratulations to Pauline Curchod for her thesis studying the reduction of incisional surgical site infections with the introduction of closed-wound negative pressure wound therapy dressings in ostomies.
Read it here 👉 https://t.co/AyVzbZtNZb
#CHVresearch#chvteachinghospital